A result of phase II clinical trial for the dermatomycosis of new antifungus external preparation KP-363 ( butenafine hydrochloride ) cream and liquid.
- 1 January 1990
- journal article
- Published by Western Japan Division of JDA in The Nishinihon Journal of Dermatology
- Vol. 52 (3) , 586-595
- https://doi.org/10.2336/nishinihonhifu.52.586
Abstract
No abstract availableKeywords
This publication has 1 reference indexed in Scilit: